RxSpan MD Tirzepatide Review: Cost, Named Pharmacies & Honest Verdict (2026)

RxSpan MD is a physician-founded telehealth practice whose standout feature is disclosure: it publishes its LegitScript certification number, names each of its individual compounding pharmacy partners — with a phone number and a domain for each — rather than referring vaguely to "US-licensed pharmacies" the way most compounded sellers do, and names the medical group that does the prescribing. It offers compounded tirzepatide alongside a genuine brand-name pathway (Zepbound, Mounjaro, Wegovy, Ozempic), though the price sits mid-to-high for this category. Every fact here comes from the company's own published program.

What RxSpan MD is

RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, whose credentials the practice publishes at length on its own about page. Its LegitScript certification is served directly from LegitScript's own CDN under certificate number #50405601 and bound to rxspanmd.com rather than to some other domain — a genuine, checkable verification. The prescribing medical group is named as Lion MD, and the operating entity is published as RxSpan MD LLC in its terms of service. RxSpan MD is a multi-vertical practice, also covering hair, sexual health, and longevity, rather than a weight-management specialist.

What RxSpan MD costs

Re-verified 2026-08-07 against RxSpan MD's own product catalog. Its storefront renders nothing to a plain fetch, so these figures were read from the catalog the storefront itself loads, and cross-checked against the plan selector a reader sees: compounded tirzepatide injections run $329/month month-to-month, stepping to $309, $289, and $269/month on three-, six-, and twelve-month plans. Oral capsules start higher at $349/month month-to-month but converge on the same ladder, and actually undercut the injection at the three-month rung — $299 against $309 — before both land at $289 and $269. Brand-name Zepbound and Mounjaro are listed at $1,069/month, with Ozempic at $1,299 and Wegovy at $1,349. Every one of those figures is unchanged from our July reading; nothing here has moved.

One inconsistency is worth naming. RxSpan MD's own FAQ answers "Are there any long-term commitments?" with "No. RXSpan MD offers flexible plans with transparent pricing." That is true in the sense that a month-to-month plan exists — but every rate below $329 requires committing to three, six or twelve months, so the cheapest prices and the no-commitment promise are not available at the same time.

Named compounding pharmacies — a rarer disclosure than it should be

Verified August 9, 2026: RxSpan MD names its individual compounding partners — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx — and publishes a phone number and a website for each one, rather than the vague "US-licensed pharmacy" language most compounded sellers use. That is a genuinely stronger transparency signal than most sibling providers in this category offer: it means you can call the pharmacy that would actually be filling your prescription before you buy anything, which is not possible at a program that names none.

Two corrections to how this page used to put it. First, we described these as 503A partners. RxSpan does not say that: the strings for either compounding designation appear nowhere on its site or in the data its FAQ loads from, checked 2026-08-09. It names the pharmacies without classifying them, so you know who may fill your prescription and not to what standard. Second, the names live in a client-hydrated FAQ, so they are invisible to anything that reads the served page — which is also why a sibling site of ours spent a day claiming RxSpan named nobody. Both facts are worth having: the disclosure is real, and it is one you have to go looking for.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

RxSpan MD offers both routes, so you're not forced into the compounded copy if brand access matters to you — though at $1,069/month, its brand Zepbound listing runs above LillyDirect's own $299-$449/month self-pay rate, worth comparing directly. See our Zepbound cost and savings guide for the branded benchmark.

How the care model holds up

RxSpan MD's real strengths: a genuinely verified LegitScript certification, physician-founded and openly attributed — unusual in compounded telehealth — four named pharmacy partners you can telephone yourself, though none of them classified, a named prescribing group and a published operating entity, and a real brand-name pathway alongside the compounded tiers. Free expedited shipping and 24/7 support are included, with coverage across all 50 states after a short assessment. The trade-offs: at $329/month month-to-month, the compounded injection sits well above the cheapest programs here, the brand-name pricing runs high even by brand standards, and the FAQ's "no long-term commitments" sits awkwardly beside a discount ladder that requires exactly that. As with any GLP-1 program, tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

RxSpan MD is worth considering for its genuine transparency — a verified LegitScript number, four named compounding pharmacies with contact details, a named prescribing group and a published operating entity — plus a real brand-name option if you want it. The trade-off is price: both the compounded and brand tiers sit above most of the field, and the rates below $329 all require a multi-month commitment. If cost is the priority, compare it against CoreAge Rx's flat $149/month rate. And on the subject of checking a provider's regulatory record directly rather than trusting a summary, see our SkinnyRx review — a provider we also link to on commission, and whose FDA warning letter we disclose everywhere we do. If a genuinely broad menu is what you're after, see Ark Health, though verifying it directly proved harder; another named-partner platform worth comparing is AVARA Rx. For a provider whose flat, published pricing this review couldn't independently reconfirm live due to client-side rendering, see Blis MD. For a provider with a similarly disclosed legal entity and address plus both compounded and brand pathways, see DrMedHealth. If your priority is the FDA-approved brand drug specifically rather than a compounded route at all, see our GoodRx review — a discount card, not a telehealth provider, but a genuine way to lower the brand-name price. See our best tirzepatide providers ranking for the full field.